{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:37Z","timestamp":1787163877169,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,15]]},"DOI":"10.7759\/cureus.40478","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T19:50:01Z","timestamp":1686858601000},"source":"Crossref","is-referenced-by-count":4,"title":["Rebound Catatonia Associated With Injectable Paliperidone"],"prefix":"10.7759","author":[{"given":"Bamidele O","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godwin","family":"Orji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi O","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Petion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Oke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana Elham","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nwabueze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodeji","family":"Jolayemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02062-w","article-title":"Benefits and harms of risperidone and paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports","volume":"19","author":"Hodkinson A","year":"2021","unstructured":"Hodkinson A, Heneghan C, Mahtani KR, Kontopantelis E, Panagioti M. Benefits and harms of risperidone and paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. BMC Med. 2021, 19:195. 10.1186\/s12916-021-02062-w","journal-title":"BMC Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11970","article-title":"Antipsychotic prescriptions among adults with major depressive disorder in office-based outpatient settings: national trends from 2006 to 2015","volume":"79","author":"Rhee TG","year":"2018","unstructured":"Rhee TG, Mohamed S, Rosenheck RA. Antipsychotic prescriptions among adults with major depressive disorder in office-based outpatient settings: national trends from 2006 to 2015. J Clin Psychiatry. 2018, 79:10.4088\/JCP.17m11970","journal-title":"J Clin Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-015-0092-x","article-title":"Comparative pharmacology of risperidone and paliperidone","volume":"15","author":"Corena-McLeod M","year":"2015","unstructured":"Corena-McLeod M. Comparative pharmacology of risperidone and paliperidone. Drugs R D. 2015, 15:163-74. 10.1007\/s40268-015-0092-x","journal-title":"Drugs R D"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00047","article-title":"The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch R","year":"2014","unstructured":"Brisch R, Saniotis A, Wolf R, et al.. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014, 5:47. 10.3389\/fpsyt.2014.00047","journal-title":"Front Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.699748","article-title":"Paliperidone 3-month injection for treatment of schizophrenia: a narrative review","volume":"12","author":"Edinoff AN","year":"2021","unstructured":"Edinoff AN, Doppalapudi PK, Orellana C, et al.. Paliperidone 3-month injection for treatment of schizophrenia: a narrative review. Front Psychiatry. 2021, 12:699748. 10.3389\/fpsyt.2021.699748","journal-title":"Front Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12295","article-title":"Signalling profile differences: paliperidone versus risperidone","volume":"170","author":"Clarke WP","year":"2013","unstructured":"Clarke WP, Chavera TA, Silva M, Sullivan LC, Berg KA. Signalling profile differences: paliperidone versus risperidone. Br J Pharmacol. 2013, 170:532-45. 10.1111\/bph.12295","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13070935","article-title":"Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics","volume":"13","author":"Toja-Camba FJ","year":"2021","unstructured":"Toja-Camba FJ, Gesto-Antelo N, Maro\u00f1as O, et al.. Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics. Pharmaceutics. 2021, 13:935. 10.3390\/pharmaceutics13070935","journal-title":"Pharmaceutics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13030035","article-title":"Paliperidone to treat psychotic disorders","volume":"13","author":"Minwalla HD","year":"2021","unstructured":"Minwalla HD, Wrzesinski P, Desforges A, et al.. Paliperidone to treat psychotic disorders. Neurol Int. 2021, 13:343-58. 10.3390\/neurolint13030035","journal-title":"Neurol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04347-7","article-title":"Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report","volume":"22","author":"Borojevic N","year":"2022","unstructured":"Borojevic N, Dawud M, Xiao J, Yun Y. Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report. BMC Psychiatry. 2022, 22:734. 10.1186\/s12888-022-04347-7","journal-title":"BMC Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4172\/2161-1459.1000117","article-title":"The pharmacological role and clinical applications of antipsychotics\u2019 active metabolites: paliperidone versus risperidone","volume":"3","author":"\u00c1lamo C","year":"2013","unstructured":"\u00c1lamo C, L\u00f3pez-Mu\u00f1oz F. The pharmacological role and clinical applications of antipsychotics\u2019 active metabolites: paliperidone versus risperidone. Clin Exp Pharmacol. 2013, 3:1000117. 10.4172\/2161-1459.1000117","journal-title":"Clin Exp Pharmacol"},{"key":"ref11","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri MC","year":"2014","unstructured":"Mauri MC, Paletta S, Maffini M, Colasanti A, Dragogna F, Di Pace C, Altamura AC. Clinical pharmacology of atypical antipsychotics: an update. EXCLI J. 2014, 13:1163-91.","journal-title":"EXCLI J"},{"key":"ref12","article-title":"Long-acting injectable paliperidone palmitate: a review of efficacy and safety","volume":"47","author":"Morris MT","year":"2017","unstructured":"Morris MT, Tarpada SP. Long-acting injectable paliperidone palmitate: a review of efficacy and safety. Psychopharmacol Bull. 2017, 47:42-52.","journal-title":"Psychopharmacol Bull"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2069880","article-title":"Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects","volume":"29","author":"Rehman S","year":"2022","unstructured":"Rehman S, Nabi B, Javed A, et al.. Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects. Drug Deliv. 2022, 29:1409-22. 10.1080\/10717544.2022.2069880","journal-title":"Drug Deliv"},{"key":"ref14","article-title":"Catatonia","author":"Burrow JP","year":"2023","unstructured":"Burrow JP, Spurling BC, Marwaha R. Catatonia.  Stat Pearls Publishing, Treasure Island, FL; 2023."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.12.036","article-title":"The diagnostic criteria and structure of catatonia","volume":"164","author":"Wilson JE","year":"2015","unstructured":"Wilson JE, Niu K, Nicolson SE, Levine SZ, Heckers S. The diagnostic criteria and structure of catatonia. Schizophr Res. 2015, 164:256-62. 10.1016\/j.schres.2014.12.036","journal-title":"Schizophr Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64012-3.00025-3","article-title":"The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia","volume":"165","author":"Sienaert P","year":"2019","unstructured":"Sienaert P, van Harten P, Rhebergen D. The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia. Handb Clin Neurol. 2019, 165:415-28. 10.1016\/B978-0-444-64012-3.00025-3","journal-title":"Handb Clin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1951965","article-title":"Malignant catatonia warrants early psychiatric-critical care collaborative management: two cases and literature review","volume":"2017","author":"Park J","year":"2017","unstructured":"Park J, Tan J, Krzeminski S, Hazeghazam M, Bandlamuri M, Carlson RW. Malignant catatonia warrants early psychiatric-critical care collaborative management: two cases and literature review. Case Rep Crit Care. 2017, 2017:1951965. 10.1155\/2017\/1951965","journal-title":"Case Rep Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen SA","year":"2016","unstructured":"Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016, 6:391-8. 10.5498\/wjp.v6.i4.391","journal-title":"World J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15818","article-title":"Malignant catatonia versus neuroleptic malignant syndrome","volume":"13","author":"Desai S","year":"2021","unstructured":"Desai S, Hirachan T, Toma A, Gerolemou A. Malignant catatonia versus neuroleptic malignant syndrome. Cureus. 2021, 13:e15818. 10.7759\/cureus.15818","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/psychiatryint4010003","article-title":"Catatonia due to general medical conditions in psychiatric patients: implications for clinical practice","volume":"4","author":"Peritogiannis V","year":"2023","unstructured":"Peritogiannis V, Rizos DV. Catatonia due to general medical conditions in psychiatric patients: implications for clinical practice. Psychiatry Int. 2023, 4:18-27. 10.3390\/psychiatryint4010003","journal-title":"Psychiatry Int"},{"key":"ref21","unstructured":"What to do if your patient misses an INVEGA SUSTENNA\u00ae dose. (2006). https.\/\/www.invegasustennahcp.com\/dosing\/dose-adjustments."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159701-rebound-catatonia-associated-with-injectable-paliperidone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:03:35Z","timestamp":1707491015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159701-rebound-catatonia-associated-with-injectable-paliperidone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.40478","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}